Thursday, May 30, 2013: 7:00 PM-8:30 PM
Post-Void Residual Measurements in MS Patients Without Urinary Symptoms
Claudia Chaves, MD, Lahey Clinic;
Rik Ganguly, BS, Lahey Clinic;
Ann Camac, MD, Lahey Clinic;
Caitlin A Dionne, RN BSN MSCN, Lahey Clinic;
MaryAnne Muriello, MD, Lahey Clinic;
Arthur Mourtzinos, MD, Lahey Clinic
Characteristics and Utilization Of MS Patients In a Commercially Insured US Population
Debra F. Eisenberg, MS, PhD, HealthCore, Inc.;
Prakash Navaratnam, Rph, MPH, PhD, DataMed Solutions LLC.;
Xuehua Ke, MA, HealthCore, Inc.;
Howard Friedman, PhD, DataMed Solutions LLC.;
Neetu Agashivala, MS, Novartis Pharmaceuticals Corporation;
Timothy L. Vollmer, MD, University of Colorado Denver
Lubiprostone for Multiple Sclerosis-Associated Constipation
Cynthia J Irish, RN, CCRC, MSCN, University of Rochester Medical Center;
Andrew D Goodman, MD, University of Rochester Medical Center;
Michael P McDermott, Ph. D., University of Rochester Medical Center;
Jason Morrissette, M.A., University of Rochester Medical Center
Urinary Symptoms Assessment and Management Among Patients With MS
Kristin M Khalaf, PharmD, MS, University of Arizona;
Karin Coyne, PhD, MPH, United Biosource Corporation;
Denise Globe, PhD, Allergan;
Edward Armstrong, PharmD, University of Arizona;
Daniel Malone, RPh, PhD, University of Arizona;
Jack Burks, MD, Florida International University
Effect Of BG-12 (Dimethyl Fumarate) On Quality Of Life In Patients With MS
Mariko Kita, MD, Virginia Mason Medical Center, Seattle, WA, USA;
Robert J. Fox, MD, FAAN, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic;
Ralf Gold, MD, Ruhr University, Bochum, Germany;
Gavin Giovannoni, PhD, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK;
J. Theodore Phillips, MD PhD FAAN, Baylor Institute for Immunology Research, Dallas, TX, USA;
Sujata P. Sarda, PhD, Weston, MA, USA;
Jessica Kong, PhD, Weston, MA, USA;
Vissia Viglietta, MD, Weston, MA, USA;
Sarah I. Sheikh, MD, MRCP, MSc, Weston, MA, USA;
Katherine T. Dawson, MD, Weston, MA, USA;
Ludwig Kappos, MD, University Hospital, Basel Neurology, Basel, Switzerland
Misoprostol For Control Of Painful Tonic Spasms
Ryan Orie, MPAS, PA-C, University of Pittsburgh Medical Center;
Margie O'Leary, RN, MSN, MSCN, University of Pittsburgh Medical Center;
Rebecca Rosiek, RN, BSN, University of Pittsburgh Medical Center;
Victoria Young, RN, BSN, University of Pittsburgh Medical Center;
Rock Heyman, MD, University of Pittsburgh Medical Center
BG-12 (Dimethyl Fumarate) Tolerability Delphi Panel
Robert J. Fox, MD, FAAN, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic;
Ralf Gold, MD, Ruhr University, Bochum, Germany;
Eva Havrdova, MD, PhD, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic;
Michael Hutchinson, FRCP, St. Vincent’s Hospital;
J. Theodore Phillips, MD PhD FAAN, Baylor Institute for Immunology Research, Dallas, TX, USA
Improved Tremor Outcomes In Natalizumab-Treated Multiple Sclerosis Patients
John R Rinker II, MD, Birmingham VA Medical Center;
Amber Salter, MPH, University of Alabama at Birmingham;
Amy Amara, MD, PhD, University of Alabama at Birmingham;
William R Meador, MD, University of Alabama at Birmingham;
Harrison C Walker, MD, University of Alabama at Birmingham;
Gary Cutter, PhD, University of Alabama
Development of An Interactive Fatigue Education Resource for Persons With MS
Karen VL Turpin, PhD Student, MSc, BScN, University of Alberta;
Nadine Akbar, PhD Candidate, MSc, University of Toronto;
Marcia Finlayson, PhD, OTR, Queens University
![[ Visit Client Website ]](images/banner.gif)